First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Carcinoma|Colorectal Carcinoma|Lung Carcinoma|Metastatic Malignant Neoplasm in the Breast|Metastatic Malignant Neoplasm in the Colon|Metastatic Malignant Neoplasm in the Lung|Metastatic Malignant Neoplasm in the Rectum|Pancreatic Carcinoma
Interventions: DRUG: 18F-αvβ6-BP
Sponsor: Julie L. Sutcliffe, Ph.D
Collaborators: National Cancer Institute (NCI)